Abstract
Aim. A scientific assessment of the main indicators of morbidity and mortality of the population from laryngeal cancer in the Far Eastern Federal District over the past ten years (2009-2019).Materials and methods. In the process of work, indicators of morbidity and mortality, reporting forms of statistical registration of oncological patients and regulatory documents of higher organizations, information on ten-year observations on the dynamics of changes in digital values of the investigated pathology were used.Results. The main data on morbidity and mortality of patients with laryngeal cancer are given in the Far Eastern Federal District, where 2019 new cases of malignant neoplasms were registered in 34152, which is 8.5% more than ten years ago. There were 2171 patients with laryngeal cancer under outpatient observation, i.e. 26.5% per 100.000 population in the region. In the structure of primary morbidity and total mortality among all departments of the respiratory system, laryngeal cancer ranked second after malignant neoplasms of the trachea, bronchi and lung. During the study period, the number of patients with advanced forms of the disease increased with a simultaneous decrease in the number of patients with stages I and II of the oncological process. Over the past ten years, the incidence of disease has increased more significantly in the female population. The percentage of actively identified patients during this time increased by several orders of magnitude, with a simultaneous increase in the index of the accumulation of populations of patients with laryngeal cancer. Morphological confirmation of the diagnosis was lower than the Russian average. The proportion of patients registered for five years or more did not reach the average republican values. Lethality in the first year since the diagnosis was established was characterized by dynamically decreasing digital values, despite the increase in the number of neglected cases, which can be explained by the high level of modern methods of treatment.Conclusion. Against the background of the increasing absolute number of patients with malignancies in the Far Eastern Federal District in 2019, there was a decrease in standardized indicators (world standard) of morbidity and mortality from laryngeal cancer in the male population, with an increase in the number of women who fell ill and died from this pathology.
Highlights
Laryngeal cancer in the Far Eastern Federal District over the past ten years (2009-2019)
The main data on morbidity and mortality of patients with laryngeal cancer are given in the Far Eastern Federal District, where 2019 new cases of malignant neoplasms were registered in 34152, which is 8.5% more than ten years ago
The percentage of actively identified patients during this time increased by several orders of magnitude, with a simultaneous increase in the index of the accumulation of populations of patients with laryngeal cancer
Summary
Научная оценка основных показателей заболеваемости и смертности населения от рака гортани в Дальневосточном федеральном округе (ДФО) за последние десять лет (2009-2019 гг.). Использованы показатели заболеваемости и смертности, отчетные формы статистического учета онкологических больных и регламентирующие документы вышестоящих организаций, информация о десятилетних наблюдениях за динамикой изменений цифровых значений исследуемой патологии. Приведены основные данные о заболеваемости и смертности больных раком гортани в ДФО, где в 2019 г. Зарегистрировано 34152 новых случая злокачественных новообразований, что на 8,5% больше, чем десять лет назад. В структуре первичной заболеваемости и общей смертности среди всех отделов дыхательной системы рак гортани занимал второе место после злокачественных новообразований трахеи, бронхов и легкого. За последние десять лет заболеваемость более существенно росла среди женского населения. Отмечалось снижение стандартизованных показателей (мировой стандарт) заболеваемости и смертности от рака гортани у мужского населения, с увеличением количества заболевших и умерших от данной патологии женщин.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.